Johnson & Johnson (JNJ) gained $0.30 to $100.85 in premarket trading after it reported fiscal-first quarter earnings. The world’s biggest maker of health care products handed in earnings of $1.56 per share on revenue of $17.37 billion, beating Wall Street estimates of $1.54 per share on revenue of $17.33 billion. However, J&J cut its full-year […]
View the full post at: Johnson & Johnson (JNJ) Beats Q1 Expectations